Capping years of criticism, Purdue Pharma will stop promoting its opioid drugs to doctors

The maker of OxyContin told its employees that it was cutting its sales force in half, leaving about 200 representatives in the U.S., who no longer will visit doctors’ offices to discuss the company’s opioid products.

Read More »

Comments

comments

LEAVE A COMMENT